NO20025135L - Antihypertensive midler og anvendelse - Google Patents

Antihypertensive midler og anvendelse

Info

Publication number
NO20025135L
NO20025135L NO20025135A NO20025135A NO20025135L NO 20025135 L NO20025135 L NO 20025135L NO 20025135 A NO20025135 A NO 20025135A NO 20025135 A NO20025135 A NO 20025135A NO 20025135 L NO20025135 L NO 20025135L
Authority
NO
Norway
Prior art keywords
antihypertensive agents
antihypertensive
agents
Prior art date
Application number
NO20025135A
Other languages
English (en)
Other versions
NO20025135D0 (no
Inventor
Bruce Jeffrey Auerbach
Karen Diane Hitchcock
Michael John Ryan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20025135D0 publication Critical patent/NO20025135D0/no
Publication of NO20025135L publication Critical patent/NO20025135L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20025135A 2000-04-26 2002-10-25 Antihypertensive midler og anvendelse NO20025135L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19985500P 2000-04-26 2000-04-26
US24228000P 2000-10-20 2000-10-20
PCT/US2001/009088 WO2001080847A2 (en) 2000-04-26 2001-03-22 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use

Publications (2)

Publication Number Publication Date
NO20025135D0 NO20025135D0 (no) 2002-10-25
NO20025135L true NO20025135L (no) 2002-11-27

Family

ID=26895229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025135A NO20025135L (no) 2000-04-26 2002-10-25 Antihypertensive midler og anvendelse

Country Status (34)

Country Link
EP (1) EP1280522B1 (no)
JP (1) JP2003531170A (no)
KR (1) KR20020091245A (no)
CN (1) CN1426299A (no)
AP (1) AP2002002665A0 (no)
AR (1) AR031104A1 (no)
AT (1) ATE283691T1 (no)
AU (1) AU2001247658A1 (no)
BG (1) BG107264A (no)
BR (1) BR0110234A (no)
CA (1) CA2405559A1 (no)
CZ (1) CZ20023459A3 (no)
DE (1) DE60107559T2 (no)
DO (1) DOP2001000150A (no)
EA (1) EA005245B1 (no)
EE (1) EE200200611A (no)
ES (1) ES2231470T3 (no)
HR (1) HRP20020936A2 (no)
HU (1) HUP0300403A3 (no)
IL (1) IL152474A0 (no)
IS (1) IS6570A (no)
MA (1) MA26894A1 (no)
MX (1) MXPA02009662A (no)
NO (1) NO20025135L (no)
NZ (1) NZ521713A (no)
OA (1) OA12252A (no)
PA (1) PA8516001A1 (no)
PE (1) PE20011308A1 (no)
PL (1) PL357906A1 (no)
PT (1) PT1280522E (no)
SK (1) SK15132002A3 (no)
SV (1) SV2002000367A (no)
TN (1) TNSN01061A1 (no)
WO (1) WO2001080847A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1045691T1 (en) * 1997-12-12 2005-04-30 Warner-Lambert Company Llc Statin-carboxyalkylether combinations
CN102898380A (zh) * 2007-06-21 2013-01-30 艾克提麦斯医药品有限公司 一种crth2 拮抗剂的胺盐
DE102008026033B4 (de) * 2008-05-30 2017-08-24 Voith Patent Gmbh Antriebsstrang mit einer hydrodynamischen Maschine
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
SK15132002A3 (sk) 2003-08-05
ATE283691T1 (de) 2004-12-15
EP1280522A2 (en) 2003-02-05
EA200200953A1 (ru) 2003-04-24
CA2405559A1 (en) 2001-11-01
CN1426299A (zh) 2003-06-25
BG107264A (en) 2003-07-31
BR0110234A (pt) 2003-03-05
PT1280522E (pt) 2005-02-28
ES2231470T3 (es) 2005-05-16
KR20020091245A (ko) 2002-12-05
PL357906A1 (en) 2004-08-09
NZ521713A (en) 2004-09-24
IL152474A0 (en) 2003-05-29
AR031104A1 (es) 2003-09-10
JP2003531170A (ja) 2003-10-21
DOP2001000150A (es) 2002-08-15
EE200200611A (et) 2004-06-15
TNSN01061A1 (en) 2005-11-10
EA005245B1 (ru) 2004-12-30
DE60107559D1 (de) 2005-01-05
NO20025135D0 (no) 2002-10-25
SV2002000367A (es) 2002-08-26
OA12252A (en) 2006-05-11
WO2001080847A2 (en) 2001-11-01
HUP0300403A2 (hu) 2003-06-28
PA8516001A1 (es) 2002-09-17
HUP0300403A3 (en) 2005-03-29
EP1280522B1 (en) 2004-12-01
AU2001247658A1 (en) 2001-11-07
DE60107559T2 (de) 2005-04-14
AP2002002665A0 (en) 2002-12-31
CZ20023459A3 (cs) 2003-05-14
IS6570A (is) 2002-09-27
PE20011308A1 (es) 2002-01-18
MA26894A1 (fr) 2004-12-20
WO2001080847A3 (en) 2002-07-18
HRP20020936A2 (en) 2004-12-31
MXPA02009662A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20024355D0 (no) Nukleosidforbindelser og anvendelser derav
NO20020343D0 (no) Kaspase-inhibitorer og anvendelse derav
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20014553D0 (no) Brönnplanlegging og konstruksjon
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO991151D0 (no) Forbindelse og anvendelse derav
DE60142978D1 (de) Chirurgisches zugangsgerät und -verfahren
DK1268425T3 (da) Carbamatcaspaseinhibitorer og anvendelse deraf
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
NO20022334L (no) Ny sammensetning og anvendelse
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
DK1339292T3 (da) Sammensætning og fremgangsmåde
IS6822A (is) Imidazól- og bezimidazól kaspasatálmar og notkun þeirra
DK1106607T3 (da) Uracilforbindelser og anvendelse deraf
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20025135L (no) Antihypertensive midler og anvendelse
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application